Keywords: Abbott Labs, Humira, Creon, Pediatric, UK launch, USA, FDA

Abbott debuts pediatric Humira in UK; gets US FDA appro for first infant-specific dosage for Creon

Article | 15 June 2011

Print This

US health care major Abbott Laboratories (NYSE: ABT) has launched a pediatric vial of its blockbuster rheumatoid arthritis drug Humira ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in